Scarica l'app Stockscreener
1.52
2.43%
0.08
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché BBLG Giù?
Forum
Previsione
Frazionamento azionario
Bone Biologics Corp Borsa (BBLG) Ultime notizie
Demineralized Bone Matrix Market Report 2026 Market Outlook Supported By A Forecast 6.3% CAGR - openPR.com
Executive pay and board elections at Bone Biologics (NASDAQ: BBLG) - Stock Titan
ADRMD Stock Price and Chart — OTC:ADRMD - TradingView
Bone Biologics Corp (BBLG) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bone Biologics Corp (BBLG) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bone Biologics Corp (BBLGW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Bone Biologics Corp (BBLG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bone Biologics Corp (BBLG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bone Biologics Corp (BBLG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bone Biologics Corp (BBLG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bone Biologics Corp (BBLG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bone Biologics Corp (BBLG) Institutional Confidence - TradingKey
Bone Biologics Corp (BBLG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bone Biologics Corp (BBLGW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bone Biologics Corp (BBLGW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bone Biologics Corp (BBLGW) Institutional Confidence - TradingKey
Bone Biologics Corp (BBLGW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bone Biologics Corp (BBLGW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bone Biologics Corp (BBLGW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bone Biologics Corp (BBLGW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bone Biologics Corp (BBLGW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BBLG Q1 2026 Earnings: Narrower-than-Expected Loss Offers Some Relief as Pipeline Progress ContinuesEPS Estimate Trend - newsline.com
BBLG | Bone Biologics Corp Common Insider Trading - Quiver Quantitative
BBLG Q1 2026 Earnings: EPS Beat on Narrower Loss, Stock Dips SlightlyDiluted EPS Report - newsline.com
Bone Biologics Corp (BBLG) Edges Lower Amid Light Trading – Key Support Level in FocusBreadth Thrust - newsline.com
Bone Biologics Corp (BBLG) Edges Lower in Quiet Trading, Holding Above $1.19 SupportBear Flag - newsline.com
Bone Biologics Corp Warrants (BBLGW) Remains Steady at $14.0, Navigating Key Support and Resistance LevelsEnding Diagonal - newsline.com
Bone Biologics Corp Warrants (BBLGW) Surge Over 9%: Key Levels and OutlookOBV Trend Line - newsline.com
From trade-secret suit to Chapter 11: How a San Antonio biotech firm unraveled - San Antonio Express-News
Why Marvell Technology Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket - Benzinga
Asia Demineralized Bone Matrix Allograft MaterialsMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
BBLG Q1 2026 Earnings: Narrower-than-Expected Loss Per ShareRevenue Miss Report - newsline.com
Bone Biologics Corp (BBLG) Edges Higher as Stock Tests Key Technical LevelsATR Stop - newsline.com
NUWE Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
World Demineralized bone matrix allograft materialsMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
BBLG Q1 2026 Earnings: Smaller-than-Expected Loss on No Revenue as Bone Graft Developer Continues R&D ProgressGAAP Earnings Report - The Legal Advocate
Patagonia Files Trademark Lawsuit Against Drag Queen Pattie Gonia Over Branding UseRevenue Beat Analysis - dars.gov.et
Bone Biologics Corp (BBLG) Surges 5.24% — Can It Hold Above Key Resistance?Factor Rotation - The Legal Advocate
Bone Growth Stimulators Market Size to Hit USD 3.84 Bn by 2035 - Precedence Research
Bone Biologics Corp (BBLG) Tests Support After Marginal DeclineIsland Reversal - dars.gov.et
BBLGBone Biologics Corp Stock Price and Quote - Finviz
Bone Biologics Corp (BBLG) Rises 3.28% as Stock Approaches Resistance LevelFundamental Weighted - The Legal Advocate
Bone Biologics Corp Warrants (BBLGW) Holding Steady at $14.15 After a Flat SessionBullish Pattern Stocks - The Legal Advocate
World Bone Graft SubstitutesMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
BBLG Q1 2026 Earnings: Narrower-than-Expected Loss as Company Advances Bone Graft PlatformROIC Trend Report - Newser
BBLG Q1 2026 Earnings: Narrowed Loss Beats Estimates as Bone Biologics Advances PipelineBook Value Growth - The Legal Advocate
BBLG Q1 2026 Earnings: EPS Surprises to the Upside Despite No Revenue; Stock DeclinesAI Trading Community - Newser
Bone Biologics Corp (BBLG) Q1 2026 Earnings: Narrower Loss Beats Estimates, Shares DipSocial Signal Watchlist - Newser
BBLG Q1 2026 Earnings: Narrower-than-Expected Loss as Bone Biologics Advances DevelopmentFree Stock Community - Newser
Bone Biologics extends rhNELL-1 protein shelf life to 29 months - Investing.com
Spine fusion protein from Bone Biologics now lasts 29 months - Stock Titan
1.03%
2.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):